Extended overall survival results from the POLO study of active maintenance olaparib in patients with metastatic pancreatic cancer and a germline BRCA mutation Meeting Abstract


Authors: Arnold, D.; Hammel, P.; Golan, T.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Oh, D. Y.; Reinacher-Schick, A.; Tortora, G.; Algül, H.; O'reilly, E. M.; Sharan, K.; Ou, X.; Cui, K.; Locker, G. Y.; Kindler, H. L.
Abstract Title: Extended overall survival results from the POLO study of active maintenance olaparib in patients with metastatic pancreatic cancer and a germline BRCA mutation
Meeting Title: 2022 Deutscher Krebskongress. Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung
Journal Title: Oncology Research and Treatment
Volume: 45
Issue: Suppl. 3
Meeting Dates: 2022 Nov 13-16
Meeting Location: Berlin, Germany
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2022-11-01
Start Page: 90
End Page: 91
Language: English
ACCESSION: WOS:000883051700213
PROVIDER: wos
DOI: 10.1159/000521004
Notes: Meeting Abstract: 950 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly